# Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence

> **NCT00563797** · PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 21 (actual)

## Conditions studied

- Alcohol Dependence
- Depression

## Interventions

- **DRUG:** Mecamylamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00563797
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563797, "Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00563797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*